Application 020781
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZOFRAN ODT | ONDANSETRON | TABLET, ORALLY DISINTEGRATING;ORAL | 4MG | Yes | No |
| 002 | ZOFRAN ODT | ONDANSETRON | TABLET, ORALLY DISINTEGRATING;ORAL | 8MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020781-001 | ZOFRAN ODT | ONDANSETRON | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | |
| N020781-002 | ZOFRAN ODT | ONDANSETRON | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020781-001 | ZOFRAN ODT | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020781-002 | ZOFRAN ODT | 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020781-001 | ZOFRAN ODT | 4MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020781-002 | ZOFRAN ODT | 8MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020781-001 | ZOFRAN ODT | 4MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020781-002 | ZOFRAN ODT | 8MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020781-001 | ZOFRAN ODT | 4MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020781-002 | ZOFRAN ODT | 8MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020781-001 | ZOFRAN ODT | 4MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RLD | 1999-01-27 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020781-002 | ZOFRAN ODT | 8MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RLD, RS | 1999-01-27 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N020781-001 | ZOFRAN ODT | 4MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020781-002 | ZOFRAN ODT | 8MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020781-001 | ZOFRAN ODT | 4MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020781-002 | ZOFRAN ODT | 8MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD | 1999-01-27 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020781-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020781-002 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020781-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020781-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N020781-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N020781-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N020781-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N020781-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N020781-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N020781-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N020781-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N020781-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N020781-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020781-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N020781-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020781-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | Sportpharm LLC | 3c4cda2f-13d9-42c5-b449-77deb06c8de5 | 2026-08-03 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | A-S Medication Solutions | 5a81a39b-051b-414e-a6b0-d844de4e9ab4 | 2026-07-29 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | A-S Medication Solutions | 02ddd5f5-76d3-4f1c-9af3-d39e05a19c29 | 2026-07-29 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | St. Mary's Medical Park Pharmacy | 41366a20-0727-0446-e063-6294a90a957f | 2026-07-28 | Warnings, Adverse reactions | ONDANSETRON |
| ONDANSETRON | ONDANSETRON | Henry Schein, Inc. | 1a44601b-c31c-4779-a688-28cc4cc75e8b | 2026-07-23 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | HAWAII REPACK, INC. | b76c5cc9-f1ca-428b-8989-36a66802b650 | 2026-07-17 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | 18063a64-a4c0-4bad-911b-00df5c7bb65d | 2026-07-07 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | 9c3ad9c1-474e-4331-a017-09cec46702d8 | 2026-07-07 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | 77397df5-5a4f-41b2-98bc-f817a1e497fc | 2026-07-02 | Warnings, Adverse reactions | ONDANSETRON |
| ONDANSETRON | ONDANSETRON | Sportpharm LLC | de72f1ec-75dd-4659-a1a0-32b28b72c799 | 2026-07-02 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | Sportpharm LLC | 822404ad-af08-4c62-ae38-7d9819e86079 | 2026-07-01 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | St. Mary's Medical Park Pharmacy | 3207cf04-73b7-24ce-e054-00144ff8d46c | 2026-06-30 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals,Inc | 4575d288-be0c-f6c3-e063-6294a90af708 | 2026-06-29 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 1b9c2d9f-62a8-4d26-a041-a598bc59e300 | 2026-06-26 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 3c34ca82-9705-4784-be7c-8b50351d14fc | 2026-06-12 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | Preferred Pharmaceuticals Inc. | e87a5803-e872-43f7-8a15-79aa236e8c07 | 2026-06-11 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | BluePoint Laboratories | ed1132ec-c2cd-4646-b69d-26663bb937a4 | 2026-06-10 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | American Health Packaging | 92b96072-e8f2-4fd6-aaa0-b73fed214319 | 2026-06-01 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | Hospira, Inc. | d62cd60b-f87e-4825-bead-1d18bbc4e480 | 2026-05-23 | Warnings, Adverse reactions | ONDANSETRON |
| Ondansetron | ONDANSETRON | Hospira, Inc. | 6a11f61b-2318-4382-2b91-4366e4bb53fa | 2026-05-22 | Warnings, Adverse reactions | ONDANSETRON |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0078-0679 | ZOFRAN | ondansetron hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0679 | ZOFRAN | ondansetron hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0680 | ZOFRAN | ondansetron hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0680 | ZOFRAN | ondansetron hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82444 | SUPPL | 2025-06-04 |
| 82443 | SUPPL | 2025-06-03 |
| 69073 | SUPPL | 2021-10-22 |
| 69056 | SUPPL | 2021-10-21 |
| 67248 | SUPPL | 2021-04-29 |
| 67242 | SUPPL | 2021-04-29 |
| 54223 | SUPPL | 2018-05-17 |
| 49978 | SUPPL | 2017-10-06 |
| 49964 | SUPPL | 2017-10-06 |
| 45881 | SUPPL | 2016-11-10 |
| 45877 | SUPPL | 2016-11-10 |
| 45486 | SUPPL | 2016-09-30 |
| 25822 | SUPPL | 2014-09-23 |
| 13429 | SUPPL | 2014-09-22 |
| 3345 | SUPPL | 2013-12-13 |
| 35350 | SUPPL | 2013-12-11 |
| 44070 | ORIG | 2011-12-20 |
| 35349 | SUPPL | 2011-09-16 |
| 25821 | SUPPL | 2011-09-16 |
| 13428 | SUPPL | 2010-09-29 |
| 3344 | SUPPL | 2010-09-27 |
| 20949 | SUPPL | 2007-09-26 |
| 25820 | SUPPL | 2006-09-18 |
| 35348 | SUPPL | 2006-08-23 |
| 25819 | SUPPL | 2006-01-06 |
| 13427 | SUPPL | 2004-12-03 |
| 3343 | SUPPL | 2004-12-02 |
| 25818 | SUPPL | 2004-07-01 |
| 41698 | ORIG | 1999-01-27 |
| 25817 | ORIG | 1999-01-27 |
| 13426 | ORIG | 1999-01-27 |